{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-080662","form_type":"8-K","ticker":"INM","cik":"0001728328","company_name":"InMed Pharmaceuticals Inc.","filed_at":"2024-09-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.331898+00:00","generated_at":"2026-05-31T02:49:14.255291+00:00","sec_items":["3.01","7.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"InMed receives Nasdaq delisting notice for bid price non-compliance; hearing set for Oct 31, 2024","bullets":["Nasdaq Staff issued delisting notice on Sept 17, 2024, after company failed to meet minimum $1.00 bid price by Sept 16, 2024 compliance deadline.","Company timely filed an appeal; hearing before Nasdaq Listing Qualifications Panel scheduled for October 31, 2024.","Appeal stays delisting pending panel decision; panel may grant up to 180 additional calendar days to regain compliance.","No guarantee extension will be granted or that outcome will be favorable; shares risk suspension or delisting.","Previously received 180-day extension on March 19, 2024 to cure deficiency."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-080662","json":"https://secwatch.observer/filing/0001213900-24-080662.json","markdown":"https://secwatch.observer/filing/0001213900-24-080662.md","text":"https://secwatch.observer/filing/0001213900-24-080662.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1728328/000121390024080662/0001213900-24-080662-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1728328/000121390024080662/ea0215298-8k_inmed.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T02:49:14.255291+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}